Subcutaneous (Sc) Dosing Of Recombinant Human Interleukin-21 (Ril-21) Is Safe And Has Clinical Activity: Results From A Dose-Escalation Study In Stage 4 Melanoma (Mm) Or Renal Cell Cancer (Rcc)
JOURNAL OF CLINICAL ONCOLOGY（2008）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要